Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000805928-22-000079
Filing Date
2022-07-19
Accepted
2022-07-19 16:02:16
Documents
3
Period of Report
2022-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165826091626398.html 4  
1 FORM 4 wf-form4_165826091626398.xml 4 3992
2 POA burke_w.htm EX-24 4348
3 POA-GRAPHICS burke_w001.jpg GRAPHIC 245898
  Complete submission text file 0000805928-22-000079.txt   348775
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Issuer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address HAEMONETICS CORPORATION 400 WOOD ROAD BRAINTREE MA 02184
Business Address
Burke William P. Mr. (Reporting) CIK: 0001682069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36046 | Film No.: 221091576